Modeling a seeded continuous crystallizer for the production of active pharmaceutical ingredients

被引:35
|
作者
Besenhard, M. O. [1 ,2 ]
Hohl, R. [1 ]
Hodzic, A. [1 ]
Eder, R. J. P. [3 ]
Khinast, J. G. [1 ,3 ]
机构
[1] Res Ctr Pharmaceut Engn RCPE GmbH, A-8010 Graz, Austria
[2] Siemens AG, Corp Technol, A-8054 Graz, Austria
[3] Graz Univ Technol, Inst Proc & Particle Engn, A-8010 Graz, Austria
关键词
continuous crystallization; PBE modeling; sensitivity analysis; aggregation; supersaturation control; POPULATION BALANCE-EQUATIONS; AGGREGATION-BREAKAGE PROCESSES; PREFERENTIAL CRYSTALLIZATION; INDUSTRIAL CRYSTALLIZATION; ACETYLSALICYLIC-ACID; QUADRATURE METHOD; TURBULENT FLUID; PIVOT TECHNIQUE; PRECIPITATION; AGGLOMERATION;
D O I
10.1002/crat.201300305
中图分类号
O7 [晶体学];
学科分类号
0702 ; 070205 ; 0703 ; 080501 ;
摘要
The approximation of a well mixed reactor is prevalent when it comes to the modeling of a crystallization process. Since temperature, concentration, and mass content vary due to inhomogeneous mixing, this approximation is a very loose one. The continuously operated seeded tubular crystallizer system developed in our group overcomes obstacles like a slow response to changes in the outer parameters and inhomogeneous mixing. Therefore the applicable well mixed assumption facilitates detailed modeling of the crystallization process by means of population balance equations (PBE) coupled with mass and energy balances. Modeled results were validated by means of experiments. The amount of aggregation events during the crystallization could be quantified and it was proven that the growth of seeded crystals is almost exclusively responsible for solid mass uptake if the reactor is operated appropriately. The performed sensitivity analysis exposed which process settings should be maintained most accurately to avoid fluctuations in the product crystals' quality attributes and to limit undesired nucleation events.
引用
收藏
页码:92 / 108
页数:17
相关论文
共 50 条
  • [1] Continuously Seeded, Continuously Operated Tubular Crystallizer for the Production of Active Pharmaceutical Ingredients
    Eder, Rafael J. P.
    Radl, Stefan
    Schmitt, Elisabeth
    Innerhofer, Sabine
    Maier, Markus
    Gruber-Woelfler, Heidrun
    Khinast, Johannes G.
    [J]. CRYSTAL GROWTH & DESIGN, 2010, 10 (05) : 2247 - 2257
  • [2] Continuous processes for the production of pharmaceutical intermediates and active pharmaceutical ingredients
    LaPorte, Thomas L.
    Wang, Chenchi
    [J]. CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2007, 10 (06) : 738 - 745
  • [3] Enabling precision manufacturing of active pharmaceutical ingredients: workflow for seeded cooling continuous crystallisations
    Brown, Cameron J.
    McGlone, Thomas
    Yerdelen, Stephanie
    Srirambhatla, Vijay
    Mabbott, Fraser
    Gurung, Rajesh
    Briuglia, Maria L.
    Ahmed, Bilal
    Polyzois, Hector
    McGinty, John
    Perciballi, Francesca
    Fysikopoulos, Dimitris
    MacFhionnghaile, Pol
    Siddique, Humera
    Raval, Vishal
    Harrington, Tomas S.
    Vassileiou, Antony D.
    Robertson, Murray
    Prasad, Elke
    Johnston, Andrea
    Johnston, Blair
    Nordon, Alison
    Srai, Jagjit S.
    Halbert, Gavin
    ter Horst, Joop H.
    Price, Chris J.
    Rielly, Chris D.
    Sefcik, Jan
    Florence, Alastair J.
    [J]. MOLECULAR SYSTEMS DESIGN & ENGINEERING, 2018, 3 (03): : 518 - 549
  • [4] Heterogeneous nucleation of active pharmaceutical ingredients on polymers: Applications in continuous pharmaceutical manufacturing
    Tan, Li
    Myerson, Allan
    Trout, Bernhardt
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [5] Towards the sustainable and continuous in-vitro production of active pharmaceutical ingredients from medicinal plants
    Michoux, F.
    Nixon, P. J.
    [J]. PLANTA MEDICA, 2011, 77 (12) : 1281 - 1281
  • [6] An Approach to the Commercial Production of Highly Active Pharmaceutical Ingredients
    Beyeler, Andreas
    Wilhelm, Roland
    Brodbeck, Bernd
    [J]. CHIMIA, 2016, 70 (09) : 596 - 603
  • [7] Understanding flow chemistry for the production of active pharmaceutical ingredients
    Burange, Anand S.
    Osman, Sameh M.
    Luque, Rafael
    [J]. ISCIENCE, 2022, 25 (03)
  • [8] Continuous Manufacturing of Active Pharmaceutical Ingredients: Current Trends and Perspectives
    Hyer, Andres
    Gregory, Daniel
    Kay, Kaitlin
    Le, Quang
    Turnage, Justin
    Gupton, Frank
    Ferri, James K.
    [J]. ADVANCED SYNTHESIS & CATALYSIS, 2024, 366 (03) : 357 - 389
  • [9] Mathematical analysis of a seeded, nonnucleating continuous zeolite crystallizer
    Pittenger, BH
    Thompson, RW
    [J]. ZEOLITES, 1996, 17 (03): : 272 - 277
  • [10] Seeded precipitations stirred tank reactor in the continuous crystallizer
    Leubner, IH
    [J]. JOURNAL OF DISPERSION SCIENCE AND TECHNOLOGY, 2001, 22 (04) : 373 - 380